The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression
Open accessAbstract
microRNAs in the miR-106b family are overexpressed in multiple tumor types and are correlated with the expression of genes that regulate the cell cycle. Consistent with these observations, miR-106b family gain of function promotes cell cycle progression, whereas loss of function reverses this phenotype. Microarray profiling uncovers multiple targets of the family, including the cyclin-dependent kinase inhibitor p21/CDKN1A. We show that p21 is a direct target of miR-106b and that its silencing plays a key role in miR-106b-induced cell cycle phenotypes. We also show that miR-106b overrides a doxorubicin-induced DNA damage checkpoint. Thus, miR-106b family members contribute to tumor cell proliferation in part by regulating cell cycle progression and by modulating checkpoint functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have shown that miR-106b targets several genes implicated in cell cycles, such as cyclin-dependent kinase inhibitor 1A (p21), E2F transcription factor, TAF5-like RNA polymerase II, and phosphatase and tensin homolog (Ivanovska et al., 2008; Pichiorri et al., 2008; Poliseno et al., 2010; Trompeter et al., 2011).”
From miR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression (2012) · cites this paper as Ivanovska et al., 2008
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Prediction of Mammalian MicroRNA Targets
Lewis, B. P., Shih, I.-H., Jones-Rhoades, M. W., Bartel, D. P., & Burge, C. B. (2003) · Cell · doi:10.1016/s0092-8674(03)01018-3 · Cited by 5,199
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
Self-citationRAS Is Regulated by the let-7 MicroRNA Family
Johnson, S., Großhans, H., Shingara, J., Byrom, M., JARVIS, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,699
A microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando, E., Mu, D., Goodson, S. G., Powers, S., Cordon‐Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,642
A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A. O., Landthaler, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.040 · Cited by 3,626
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,579
Research works printed but not linked: 1
- Waldman T., 1995, Cancer Res., 55, 5187
Cited by
Sorted by citations
Jansson, M., & Lund, A. H. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.006 · Cited by 1,150
miRiad Roles for the miR-17-92 Cluster in Development and Disease
Mendell, J. T. (2008) · Cell · doi:10.1016/j.cell.2008.04.001 · Cited by 1,086
Ambs, S., Prueitt, R. L., Yi, M., Hudson, R. S., Howe, T. M., Petrocca, F., Wallace, T. A., Liu, C., Volinia, S., Calin, G. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0144 · Cited by 705
Embryonic stem cell–specific microRNAs regulate the G1-S transition and promote rapid proliferation
Wang, Y., Baskerville, S., Shenoy, A., Babiarz, J., Baehner, L., & Blelloch, R. H. (2008) · Nature Genetics · doi:10.1038/ng.250 · Cited by 660
Kim, Y. K., Yu, J., Han, T. S., Park, S.-Y., Namkoong, B., Kim, D. H., Hur, K., Yoo, M., Lee, H.-J., Yang, H., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp002 · Cited by 476
mir-17-92, a cluster of miRNAs in the midst of the cancer network
Olive, V., Jiang, I., & He, L. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.03.004 · Cited by 476
MicroRNA regulation of Alzheimer's Amyloid precursor protein expression
Hébert, S. S., Horré, K., Nicolaï, L., Bergmans, B., Papadopoulou, A. S., Delacourte, A., & De Strooper, B. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.009 · Cited by 436
Examination of the expanding pathways for the regulation of p21 expression and activity
Jung, Y.-S., Qian, Y., & Chen, X. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.01.013 · Cited by 428
Bueno, M. J., & Malumbres, M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.02.002 · Cited by 419
Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region
Wu, S., Huang, S., Ding, J., Zhao, Y., Liang, L., Liu, T., Zhan, R., & He, X. (2010) · Oncogene · doi:10.1038/onc.2010.34 · Cited by 346
Petrocca, F., Vecchione, A. M., & Croce, C. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1768 · Cited by 388
Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM
Fontana, L., Fiori, M. E., Albini, S., Cifaldi, L., Giovinazzi, S., Forloni, M., Boldrini, R., Donfrancesco, A., Federici, V., Giacomini, P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002236 · Cited by 394
MicroRNA-29 Regulates T-Box Transcription Factors and Interferon-γ Production in Helper T Cells
Steiner, D. F., Thomas, M. F., Hu, J. K., Yang, Z., Babiarz, J., Allen, C. D. C., Matloubian, M., Blelloch, R. H., & Ansel, K. M. (2011) · Immunity · doi:10.1016/j.immuni.2011.07.009 · Cited by 365
Clustered miRNAs and their role in biological functions and diseases
Kabekkodu, S. P., Shukla, V., Varghese, V. K., Souza, J. D., Chakrabarty, S., & Satyamoorthy, K. (2018) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12428 · Cited by 364
miR‐17, miR‐19b, miR‐20a, and miR‐106a are down‐regulated in human aging
Hackl, M., Brunner, S. M., Fortschegger, K., Schreiner, C., Mičutková, L., Mück, C., Laschober, G. T., Lepperdinger, G., Sampson, N., Berger, P., et al. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00549.x · Cited by 360
Burroughs, A. M., Ando, Y., de Hoon, M., Tomaru, Y., Nishibu, T., Ukekawa, R., Funakoshi, T., Kurokawa, T., Suzuki, H., Hayashizaki, Y., et al. (2010) · Genome Research · doi:10.1101/gr.106054.110 · Cited by 346
Podocyte-Selective Deletion of Dicer Induces Proteinuria and Glomerulosclerosis
Shi, S., Yu, L., Chiu, C., Sun, Y., Chen, J., Khitrov, G., Merkenschlager, M., Holzman, L. B., Zhang, W., Mundel, P., et al. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008030312 · Cited by 349
Reprogramming of miRNA networks in cancer and leukemiaPreprint
Volinia, S., Galasso, M., Costinean, S., Tagliavini, L., Gamberoni, G., Drusco, A., Marchesini, J., Mascellani, N., Sana, M., Jarour, R. A., et al. (2010) · Genome Research · doi:10.1101/gr.098046.109 · Cited by 346
Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
Georges, S. A., Biery, M. C., Kim, S., Schelter, J. M., Guo, J., Chang, A. N., Jackson, A. L., Carleton, M. O., Linsley, P. S., Cleary, M. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1846 · Cited by 348
Self-citationControl of cell proliferation pathways by microRNAs
Bueno, M. J., de Castro, I. P., & Malumbres, M. (2008) · Cell Cycle · doi:10.4161/cc.7.20.6833 · Cited by 352
MicroRNA and cancer – focus on apoptosis
Wang, Y., & Lee, C. G. L. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00510.x · Cited by 335
Ionizing Radiation-Induced Oxidative Stress Alters miRNA Expression
Simone, N. L., Soule, B. P., Ly, D., Saleh, A. D., Savage, J. E., DeGraff, W., Cook, J. A., Harris, C. C., Gius, D. R., & Mitchell, J. B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006377 · Cited by 338
Lost in translation: an assessment and perspective for computational microRNA target identification
Alexiou, P., Maragkakis, M., Papadopoulos, G. L., Reczko, M., & Hatzigeorgiou, A. G. (2009) · Computer applications in the biosciences · doi:10.1093/bioinformatics/btp565 · Cited by 330
Dysregulation of microRNAs in cancer: Playing with fire
Melo, S. A., & Esteller, M. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.08.009 · Cited by 324
MicroRNAs in Alzheimer’s Disease
Wang, M., Qin, L., & Tang, B. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00153 · Cited by 312
Targeting of mRNAs by multiple miRNAs: the next step
Peter, M. E. (2010) · Oncogene · doi:10.1038/onc.2010.59 · Cited by 309
Small RNA‐mediated regulation of iPS cell generation
Li, Z., Yang, C., Nakashima, K., & Rana, T. M. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.2 · Cited by 308
The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy
Kreis, N., Louwen, F., & Yuan, J. (2019) · Cancers · doi:10.3390/cancers11091220 · Cited by 309
Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
Mattioli, R., Ilari, A., Colotti, B., Mosca, L., Fazi, F., & Colotti, G. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101205 · Cited by 323
Kan, T., Sato, F., Ito, T., Matsumura, N., David, S., Cheng, Y., Agarwal, R., Paun, B. C., Jin, Z., Olaru, A., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.002 · Cited by 267
miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer
Soon, P. S. H., Tacon, L. J., Gill, A. J., Bambach, C. P., Sywak, M. S., Campbell, P. R., Yeh, M. W., Wong, S. G., Clifton-Bligh, R. J., Robinson, B. G., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1587 · Cited by 262
MYC Oncogene Contributions to Release of Cell Cycle Brakes
García-Gutiérrez, L., Delgado, M. D., & León, J. (2019) · Genes · doi:10.3390/genes10030244 · Cited by 264
Role of the miR‐106b‐25 microRNA cluster in hepatocellular carcinoma
Yang, L., Tan, W., Neo, T. W. L., Aung, M. O., Wasser, S., Lim, S. G., & Tan, T. M. C. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01164.x · Cited by 255
Aschrafi, A., Schwechter, A. D., Mameza, M. G., Natera-Naranjo, O., Gioio, A. E., & Kaplan, B. B. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3338-08.2008 · Cited by 261
Diosdado, B., van de Wiel, M. A., Droste, J. S. T. S., Mongera, S., Postma, C., Meijerink, W. J. H. J., Carvalho, B. G., & Meijer, G. A. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605037 · Cited by 250
MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes
Inomata, M., Tagawa, H., Guo, Y., Kameoka, Y., Takahashi, N., & Sawada, K. (2008) · Blood · doi:10.1182/blood-2008-07-163907 · Cited by 254
Shi, H., Xu, J., Zhang, G., Xu, L., Li, C., Wang, L., Zhao, Z., Jiang, W., Guo, Z., & Li, X. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-101 · Cited by 241
Dutto, I., Tillhon, M., Cazzalini, O., Stivala, L. A., & Prosperi, E. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1430-4 · Cited by 242
The role of microRNAs in liver cancer progression
Huang, S., & He, X. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6606010 · Cited by 234
Hu, S., Dong, T. S., Dalal, S. R., Wu, F., Bissonnette, M., Kwon, J. H., & Chang, E. B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016221 · Cited by 233
Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer
Koster, R., di Pietro, A., Timmer‐Bosscha, H., Gibcus, J. H., van den Berg, A., Suurmeijer, A. J. H., Bischoff, R., Gietema, J. A., & de Jong, S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41939 · Cited by 227
Identification of a MicroRNA Panel for Clear-cell Kidney Cancer
Juan, D., Alexe, G., Antes, T. J., Liu, H., Madabhushi, A., DeLisi, C., Ganesan, S., Bhanot, G. V., & Liou, L. S. (2009) · Urology · doi:10.1016/j.urology.2009.10.033 · Cited by 225
Cell Cycle Regulation of Stem Cells by MicroRNAs
Mens, M. M. J., & Ghanbari, M. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9808-y · Cited by 224
Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis
Wang, Y. X., Zhang, X. Y., ZHANG, B. F., Yang, C. Q., Chen, X. M., & Heng Jun, G. A. O. (2010) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2009.00413.x · Cited by 217
Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
Grasso, M., Piscopo, P., Confaloni, A., & Denti, M. (2014) · Molecules · doi:10.3390/molecules19056891 · Cited by 208
Brett, J. O., Renault, V. M., Rafalski, V. A., Webb, A. E., & Brunet, A. (2011) · Aging · doi:10.18632/aging.100285 · Cited by 207
MicroRNA MiR-17 retards tissue growth and represses fibronectin expression
Shan, S. W., Lee, D. Y., Deng, Z., Shatseva, T., Jeyapalan, Z., Du, W. W., Zhang, Y., Xuan, J. W., Yee, S., Siragam, V., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1917 · Cited by 206
Spatial sorting enables comprehensive characterization of liver zonation
Ben-Moshe, S., Shapira, Y., Moor, A. E., Halpern, K. B., & Itzkovitz, S. (2019) · doi:10.1101/529784 · Cited by 205
Spatial sorting enables comprehensive characterization of liver zonation
Ben-Moshe, S., Shapira, Y., Moor, A. E., Manco, R., Veg, T., Bahar Halpern, K., & Itzkovitz, S. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0109-9 · Cited by 205
MicroRNAs and cancer: Key paradigms in molecular therapy (Review)
Tan, W., Liu, B., Qu, S., Liang, G., Luo, W., & Gong, C. (2017) · Oncology Letters · doi:10.3892/ol.2017.7638 · Cited by 200
Liu, X., Jiang, L., Wang, A., Yu, J., Shi, F., & Zhou, X. C. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.05.030 · Cited by 197
Clinical update on cancer: molecular oncology of head and neck cancer
Suh, Y., Amelio, I., Urbano, T. G., & Tavassoli, M. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.548 · Cited by 195
Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation
Huang, S., Wang, L.-L., Xue, N., Li, C., Guo, H., Ren, T., Zhan, Y., Li, W., Zhang, J., Chen, X., et al. (2019) · Theranostics · doi:10.7150/thno.34674 · Cited by 188
Myc Represses Primitive Endoderm Differentiation in Pluripotent Stem Cells
Smith, K. N., Singh, A. M., & Dalton, S. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.06.023 · Cited by 190
MicroRNAs in Alzheimer's disease
Delay, C., Mandemakers, W., & Hébert, S. S. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.01.003 · Cited by 185
MicroRNA and gene expression patterns in the differentiation of human embryonic stem cells
Ren, J., Jin, P., Wang, E., Marincola, F. M., & Stroncek, D. F. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-20 · Cited by 184
Lerner, M., Harada, M., Lovén, J., Castro, J., Davis, Z. A., Oscier, D. G., Arsenian‐Henriksson, M., Sangfelt, O., Grandér, D., & Corcoran, M. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.07.001 · Cited by 181
let‐7 and miR‐17‐92: Small‐sized major players in lung cancer development
Osada, H., & Takahashi, T. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01707.x · Cited by 183
MicroRNAs: new players in the DNA damage response
Hu, H., & Gatti, R. A. (2010) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq042 · Cited by 186
MicroRNA target prediction by expression analysis of host genesPreprint
Gennarino, V. A., Sardiello, M., Avellino, R., Meola, N., Maselli, V., Anand, S., Cutillo, L., Ballabio, A., & Banfi, S. (2008) · Genome Research · doi:10.1101/gr.084129.108 · Cited by 177
Wong, P., 岩崎, 正., Somervaille, T. C. P., Ficara, F., Carico, C., Arnold, C. P., Chen, C., & Cleary, M. L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3268 · Cited by 179
Self-citationmiR-17∼92 cooperates with RB pathway mutations to promote retinoblastomaPreprint
Conkrite, K., Sundby, M., Mukai, S., Thomson, J. M., Mu, D., Hammond, S. M., & MacPherson, D. (2011) · Genes & Development · doi:10.1101/gad.17027411 · Cited by 178
miR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression
Kim, J., Yoon, H., Ramírez, C. M., Lee, S.-M., Hoe, H.-S., Fernández-Hernando, C., & Kim, J. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.010 · Cited by 173
MicroRNAs of the immune system
Davidson-Moncada, J. K., Papavasiliou, F. N., & Tam, W. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05121.x · Cited by 175
MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN
Wang, F., Li, T., Zhang, B., Li, H., Wu, Q., Li, Y., Nie, Y., Wu, K., Shi, Y., & Fan, D. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.010 · Cited by 171
Mathis, C., Poussin, C., Weisensee, D., Gebel, S., Hengstermann, A., Sewer, A., Belcastro, V., Xiang, Y., Ansari, S., Wagner, S., et al. (2013) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00181.2012 · Cited by 169
microRNAs regulate human embryonic stem cell division
Qi, J., Yu, J., Shcherbata, H. R., Mathieu, J., Wang, A. J., Seal, S., Zhou, W., Stadler, B., Bourgin, D., Wang, L., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.22.10033 · Cited by 162
Self-citationmiR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression
Pickering, M., Stadler, B., & Kowalik, T. F. (2008) · Oncogene · doi:10.1038/onc.2008.372 · Cited by 166
Head and neck cancer: from anatomy to biology
Bose, P., Brockton, N. T., & Dort, J. C. (2013) · International Journal of Cancer · doi:10.1002/ijc.28112 · Cited by 166
Kumar, P., Luo, Y., Tudela, C. M., Alexander, J. M., & Mendelson, C. R. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01228-12 · Cited by 161
Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21Waf1/Cip1
Borgdorff, V, Lleonart, M. E., Bishop, C. L., Fessart, D., Bergin, A. H., Overhoff, M. G., & Beach, D. H. (2010) · Oncogene · doi:10.1038/onc.2009.497 · Cited by 160
Kurozumi, S., Yamaguchi, Y., Kurosumi, M., Ohira, M., Matsumoto, H., & Horiguchi, J. (2016) · Journal of Human Genetics · doi:10.1038/jhg.2016.89 · Cited by 159
MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer
Zheng, L., Zhang, Y., Liu, Y., Zhou, M., Lu, Y., Li, Y., Zhang, C., Hong, M., Wang, S., & Li, X. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0592-z · Cited by 159
Wang, Y., Gao, X., Wei, F., Zhang, X., Yu, J., Zhao, H., Sun, Q., Fan, Y. L., Yan, C., Li, H., et al. (2013) · Gene · doi:10.1016/j.gene.2013.09.038 · Cited by 158
The emerging role of miRNAs in inflammatory bowel disease: a review
Chapman, C. G., & Pekow, J. R. (2014) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x14547360 · Cited by 165
Yi, C., Wang, Q., Wang, L., Huang, Y., Li, L., Liu, L., Zhou, X., Xie, G., Kang, T., Wang, H., et al. (2012) · Oncogene · doi:10.1038/onc.2011.629 · Cited by 156
Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancers
Jamali, L., Tofigh, R., Tutunchi, S., Panahi, G., Borhani, F., Akhavan, S., Nourmohammadi, P., Ghaderian, S. M. H., Rasouli, M., & Mirzaei, H. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26850 · Cited by 154
The miR-17-92 Cluster of MicroRNAs Confers Tumorigenicity by Inhibiting Oncogene-Induced Senescence
Hong, L., Lai, M., Chen, M. S., Xie, C., Liao, R., Kang, Y. J., Xiao, C., Hu, W.-Y., Han, J., & Sun, P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1938 · Cited by 156
p53‐repressed miRNAs are involved with E2F in a feed‐forward loop promoting proliferation
Brosh, R., Shalgi, R., Liran, A., Landan, G., Korotayev, K., Nguyen, G. H., Enerly, E., Johnsen, H., Buganim, Y., Solomon, H., et al. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.65 · Cited by 153
Regulation of breast cancer metastasis signaling by miRNAs
Petri, B. J., & Klinge, C. M. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09905-7 · Cited by 158
Estrogen Regulation of MicroRNA Expression
Klinge, C. (2009) · Current Genomics · doi:10.2174/138920209788185289 · Cited by 156
MicroRNA Modulation in Obesity and Periodontitis
Perri, R., Nares, S., Zhang, S., Barros, S. P., & Offenbacher, S. (2011) · Journal of Dental Research · doi:10.1177/0022034511425045 · Cited by 149
Oncogenic MicroRNAs: Key Players in Malignant Transformation
Frixa, T., Donzelli, S., & Blandino, G. (2015) · Cancers · doi:10.3390/cancers7040904 · Cited by 151
Evolution of networks and sequences in eukaryotic cell cycle control
Cross, F. R., Buchler, N. E. G., & Skotheim, J. M. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0078 · Cited by 154
miR-17–92 cluster: ups and downs in cancer and aging
Grillari, J., Hackl, M., & Grillari‐Voglauer, R. (2010) · Biogerontology · doi:10.1007/s10522-010-9272-9 · Cited by 144
Bui, T. V., & Mendell, J. T. (2010) · Genes & Cancer · doi:10.1177/1947601910377491 · Cited by 143
Trompeter, H., Abbad, H., Iwaniuk, K. M., Hafner, M., Renwick, N. M., Tuschl, T., Schira‐Heinen, J., Müller, H. W., & Wernet, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016138 · Cited by 140
Cell Cycle Regulation by MicroRNAs in Embryonic Stem Cells
Wang, Y., & Blelloch, R. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0309 · Cited by 133
Imperfect centered miRNA binding sites are common and can mediate repression of target mRNAs
Martin, H. C., Wani, S., Steptoe, A. L., Krishnan, K., Nones, K., Nourbakhsh, E., Vlassov, A. V., Grimmond, S. M., & Cloonan, N. (2014) · Genome biology · doi:10.1186/gb-2014-15-3-r51 · Cited by 134
microRNAs in breast cancer development and treatment
Serpico, D., Molino, L., & Cosimo, S. D. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.11.002 · Cited by 128
Maes, O. C., Sarojini, H., & Wang, E. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21834 · Cited by 127
Hudson, R. S., Yi, M., Esposito, D., Glynn, S. A., Starks, A. M., Yang, Y., Schetter, A. J., Watkins, S. K., Hurwitz, A. A., Dorsey, T. H., et al. (2013) · Oncogene · doi:10.1038/onc.2012.424 · Cited by 98
Lu, C., Chen, J., Xu, H., Zhou, X., He, Q., Li, Y., Jiang, G., Shan, Y., Xue, B., Zhao, R., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.09.006 · Cited by 132
YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting
Sardo, F. L., Strano, S., & Blandino, G. (2018) · Cancers · doi:10.3390/cancers10050137 · Cited by 124
MicroRNA 92b Controls the G1/S Checkpoint Gene p57 in Human Embryonic Stem Cells
Sengupta, S., Nie, J., Wagner, R. J., Yang, C., Stewart, R. M., & Thomson, J. A. (2009) · Stem Cells · doi:10.1002/stem.84 · Cited by 121
Quesne, J. P. C. L., & Caldas, C. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.009 · Cited by 118
A high throughput experimental approach to identify miRNA targets in human cells
Tan, L. P., Seinen, E., Duns, G., de Jong, D., Sibon, O. C. M., Poppema, S., Kroesen, B., Kok, K., & van den Berg, A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp715 · Cited by 115
Identification of miR‐21 targets in breast cancer cells using a quantitative proteomic approach
Yang, Y., Chaerkady, R., Beer, M., Mendell, J. T., & Pandey, A. (2009) · PROTEOMICS · doi:10.1002/pmic.200800551 · Cited by 118
Bohačiaková, D., Mráz, M., Bárta, T., Plevová, K., Vinarský, V., Holubcová, Z., Jaroš, J., Dvořák, P., Pospíšilová, Š., & Hampl, A. (2012) · Stem Cells · doi:10.1002/stem.1108 · Cited by 115
Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer
Huh, J. H., Kim, T. H., Kim, K., Song, J. Y., Jung, Y., Jeong, J.-Y., Lee, M. J., Kim, Y. K., Lee, D. H., & An, H. J. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.305 · Cited by 112
Metadata
- Authors
- Ivanovska, I., Ball, A. S., Diaz, R. L., Magnus, J. F., Kibukawa, M., Schelter, J. M., Kobayashi, S. V., Lim, L., Burchard, J., Jackson, A. L., Linsley, P. S., & Cleary, M. A.
- Affiliations
- Rosetta Inpharmatics LLC, Seattle, Washington 98109
- Corresponding author
- Ivanovska, Irena
- ORCID
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2008-04-01
- Volume
- 28
- Issue
- 7
- Pages
- 2167-2174
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2268421
- OpenAlex
- W2100975741
- Cited by
- 561
- References
- 52
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 9 · 2023: 13 · 2022: 9 · 2021: 17 · 2020: 19 · 2019: 26 · 2018: 25 · 2017: 21 · 2016: 32 · 2015: 37 · 2014: 52 · 2013: 58 · 2012: 53
- FWCI
- 20.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- microRNA, CDKN1A/p21, cell cycle progression, cyclin-dependent kinase inhibitors, microRNA target regulation, tumor cell proliferation
- MeSH terms
- Breast, Cell Cycle, Cell Line, Transformed, DNA Damage, Doxorubicin, Female, Humans, Neoplasm Proteins, RNA, Messenger, RNA, Neoplasm, Genes, cdc, RNA Interference, RNA, Small Interfering, MicroRNAs, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review